2022
DOI: 10.1080/19768354.2022.2147584
|View full text |Cite
|
Sign up to set email alerts
|

Protective effect of fermented aloe extract on glutamate-induced cytotoxicity in HT22 cells

Abstract: Excessive glutamate can cause oxidative stress in neuronal cells and this can significantly contribute to the etiology of neurodegenerative disease. The present study mainly aims to investigate that aloe extract (AE) and fermented aloe extract (FAE) could protect against glutamate-induced cytotoxicity by modulating oxidative stress. In this study, both AE and FAE showed potent neuroprotective activity by inhibiting ROS and Ca 2+ concentration, increasing mitochondria membrane potential, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 41 publications
0
2
0
Order By: Relevance
“…Although the exact pathophysiology of AD is still unclear and remains inconclusive, it is difficult to treat AD, and currently, there is no cure. A limited number of drugs are used to treat dementia, including donepezil, rivastigmine, and galantamine 15,16 . Last few decades, many clinical trials of medicine for AD treatment have failed, and it is urgent to develop a new medicine.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although the exact pathophysiology of AD is still unclear and remains inconclusive, it is difficult to treat AD, and currently, there is no cure. A limited number of drugs are used to treat dementia, including donepezil, rivastigmine, and galantamine 15,16 . Last few decades, many clinical trials of medicine for AD treatment have failed, and it is urgent to develop a new medicine.…”
Section: Introductionmentioning
confidence: 99%
“…A limited number of drugs are used to treat dementia, including donepezil, rivastigmine, and galantamine. 15,16 Last few decades, many clinical trials of medicine for AD treatment have failed, and it is urgent to develop a new medicine. Ropinirole (ROP) is a nonergot dopamine agonist used to treat individuals with Parkinson's disease and restless leg syndrome for neurological improvements.…”
mentioning
confidence: 99%